Cargando…

Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo

The histopathological characteristics of Alzheimer’s disease (AD) are amyloid-β (Aβ) containing plaques and neurofibrillary tangles (NFTs) as well as neuronal and synaptic loss. Until today, the underlying mechanisms of the interplay of plaques and tangles remained unresolved. There is increasing ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckert, Anne, Schulz, Kathrin L., Rhein, Virginie, Götz, Jürgen
Formato:	Texto
Lenguaje:	English
Publicado:	Humana Press Inc 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876263/ https://www.ncbi.nlm.nih.gov/pubmed/20217279 http://dx.doi.org/10.1007/s12035-010-8109-5

Ejemplares similares

Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity
por: Eckert, Anne, et al.
Publicado: (2011)

Tau aggregation and its interplay with amyloid-β
por: Nisbet, Rebecca M., et al.
Publicado: (2014)

Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein
por: Grimm, Amandine, et al.
Publicado: (2015)

ER‐mitochondria contacts and cholesterol metabolism are disrupted by disease‐associated tau protein
por: Szabo, Leonora, et al.
Publicado: (2023)

Amyloid-Beta Interaction with Mitochondria
por: Pagani, Lucia, et al.
Publicado: (2011)

Tyrosine phosphatase STEP(61) in human dementia and in animal models with amyloid and tau pathology
por: Taylor, Deonne, et al.
Publicado: (2023)

The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
por: Ashford, J. Wesson
Publicado: (2019)

Ginkgo Biloba Extract Ameliorates Oxidative Phosphorylation Performance and Rescues Aβ-Induced Failure
por: Rhein, Virginie, et al.
Publicado: (2010)

Insights into Disease-Associated Tau Impact on Mitochondria
por: Szabo, Leonora, et al.
Publicado: (2020)

Decontamination of medical devices from pathological amyloid-β-, tau- and α-synuclein aggregates
por: Thomzig, Achim, et al.
Publicado: (2014)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
por: Mattsson‐Carlgren, Niklas, et al.
Publicado: (2021)

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
por: Ferrari-Souza, João Pedro, et al.
Publicado: (2022)

Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology
por: Sierksma, Annerieke, et al.
Publicado: (2018)

Disease‐associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria
por: Cummins, Nadia, et al.
Publicado: (2018)

Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy
por: Aroor, Alisha, et al.
Publicado: (2023)

Long-term depression links amyloid-β to the pathological hyperphosphorylation of tau
por: Taylor, Henry B.C., et al.
Publicado: (2021)

Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship
por: Grimm, Amandine, et al.
Publicado: (2012)

APOEε4 potentiates the relationship between amyloid-β and tau pathologies
por: Therriault, Joseph, et al.
Publicado: (2020)

NPT088 reduces both amyloid-β and tau pathologies in transgenic mice
por: Levenson, Jonathan M., et al.
Publicado: (2016)

Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)

Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β
por: Uematsu, Miho, et al.
Publicado: (2018)

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
por: Bellaver, Bruna, et al.
Publicado: (2023)

Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)

Levels of Cortisol in CSF Are Associated With SNAP-25 and Tau Pathology but Not Amyloid-β
por: Wang, Qing, et al.
Publicado: (2018)

JNK Activation in Alzheimer’s Disease Is Driven by Amyloid β and Is Associated with Tau Pathology
por: Solas, Maite, et al.
Publicado: (2023)

Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Aβ pathology at the lysosome
por: De Kimpe, Line, et al.
Publicado: (2012)

Tau physiology and pathomechanisms in frontotemporal lobar degeneration
por: Bodea, Liviu‐Gabriel, et al.
Publicado: (2016)

Inhibition of the Mitochondrial Enzyme ABAD Restores the Amyloid-β-Mediated Deregulation of Estradiol
por: Lim, Yun-An, et al.
Publicado: (2011)

Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
por: Sierksma, Annerieke, et al.
Publicado: (2020)

Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
por: Milà-Alomà, Marta, et al.
Publicado: (2022)

Models of β-amyloid induced Tau-pathology: the long and “folded” road to understand the mechanism
por: Stancu, Ilie-Cosmin, et al.
Publicado: (2014)

The Role of a Pathological Interaction between β-amyloid and Mitochondria in the Occurrence and Development of Alzheimer’s Disease
por: Nikolaeva, N. S., et al.
Publicado: (2022)

Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-β and tau
por: Banka, Vinay, et al.
Publicado: (2023)

Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
por: Höglund, K, et al.
Publicado: (2017)

Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later
por: Nägga, Katarina, et al.
Publicado: (2018)

Prophylactic Active Tau Immunization Leads to Sustained Reduction in Both Tau and Amyloid-β Pathologies in 3xTg Mice
por: Rajamohamedsait, Hameetha, et al.
Publicado: (2017)

New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
por: Park, Sun Ah, et al.
Publicado: (2020)

Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology
por: Ries, Miriam, et al.
Publicado: (2021)

sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-β pathology
por: Nabizadeh, Fardin
Publicado: (2023)

Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies
por: Grimm, Amandine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n6gcm56b993o6rf0e2pr91na2p